OverviewSuggest Edit

Hookipa Pharma develops prophylactic and therapeutic vaccines for the prevention and treatment of multiple infectious diseases and cancer. The company provides a proprietary technology platform, VaxwaveTM, that introduces an approach to vaccination by providing long lasting and potent stimulation of both cellular and humoral immunity.

TypePublic
Founded2011
HQWien, AT
Websitehookipapharma.com

Latest Updates

Employees (est.) (Feb 2019)60
Revenue (FY, 2019)$11.9 M(+57%)
Share Price (Feb 2021)$11.8 (+2%)
Cybersecurity ratingBMore

Hookipa Pharma Office Locations

Hookipa Pharma has offices in Wien and New York
Wien, AT (HQ)
Helmut-Qualtinger-Gasse 2
New York, NY, US
350 5th Ave #7240
Show all (2)

Hookipa Pharma Financials and Metrics

Hookipa Pharma Revenue

Hookipa Pharma's revenue was reported to be $11.94 m in FY, 2019
USD

Revenue (Q2, 2020)

6.7m

Net income (Q2, 2020)

(7.1m)

EBIT (Q2, 2020)

(9.2m)

Market capitalization (26-Feb-2021)

350.2m

Closing stock price (26-Feb-2021)

11.8

Cash (30-Jun-2020)

92.9m

EV

267.4m
Hookipa Pharma's current market capitalization is $350.2 m.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

7.6m11.9m

General and administrative expense

4.4m6.8m

R&D expense

9.8m22.0m

Operating expense total

14.2m28.8m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

2.2m4.1m2.0m3.7m6.7m

EBIT

(10.7m)(13.6m)(13.6m)(12.5m)(9.2m)

EBIT margin, %

(477%)(336%)(666%)(337%)(138%)

Interest expense

1.3m1.7m2.2m
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

61.4m48.6m113.2m

Accounts Receivable

4.9m1.5m

Prepaid Expenses

2.1m8.8m

Current Assets

70.0m62.3m128.0m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

70.5m134.9m123.7m104.5m92.9m

Accounts Receivable

1.3m3.3m1.3m2.8m4.7m

Current Assets

84.9m151.1m136.4m120.7m117.9m

PP&E

4.5m4.6m4.6m5.4m6.0m
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(12.7m)(16.2m)(43.0m)

Depreciation and Amortization

398.0k640.0k1.4m

Accounts Payable

(1.2m)3.4m4.2m

Cash From Operating Activities

(11.9m)(15.0m)(41.7m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(9.3m)(21.4m)(32.8m)(10.9m)(18.0m)

Depreciation and Amortization

566.0k1.4m2.2m409.0k887.0k

Accounts Payable

958.0k994.0k1.6m2.6m4.8m

Cash From Operating Activities

(12.1m)(23.5m)(32.9m)(7.1m)(17.7m)
USDFY, 2017

Financial Leverage

-1.7 x
Show all financial metrics

Hookipa Pharma Acquisitions / Subsidiaries

Company NameDateDeal Size
Hookipa Biotech GmbH

Hookipa Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Hookipa Pharma Online and Social Media Presence

Embed Graph

Hookipa Pharma News and Updates

Hookipa Pharma jumps 40% after FDA approval of clinical tests

Hookipa Pharma Inc. shares jumped 40% in late trading Thursday after the company announced that the Food and Drug Administration approved a study of the company's immunotherapy approach to certain cancers. Hookipa had asked the FDA for clearance on a phase 1/2 study of HB-201, and with its approval…

Hookipa Pharma to offer 6.7 million shares in IPO, priced at $14 to $16 each

Hookipa Pharma set terms for its planned initial public offering on Monday, saying it will offer 6.7 million shares priced at $14 to $16 each. The company would raise $100.5 million at the midpoint of that range. BofA Merrill Lynch, SVB Leerink and RBD are joint bookrunners on the deal with Kempen a…

Hookipa Pharma Blogs

Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine

Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine Content Import Thu, 03/04/2021 - 07:01 Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine March 4, 2021 at 7:01 …

HOOKIPA Pharma to Participate in Upcoming Investor Conferences in November

NEW YORK and VIENNA, Austria, Nov. 11, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate in two upcoming virtual

HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020

HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020 Content Import Tue, 11/03/2020 - 07:00 HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020 November 3, 2020 at 7:00 AM EST This release is a backf…

HOOKIPA Pharma to Present at Upcoming Conferences in September

NEW YORK and VIENNA, Austria, Sept. 09, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HOOKIPA’s management

HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020

HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020 Content Import Tue, 08/04/2020 - 07:00 HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020 August 4, 2020 at 7:00 AM EDT This release is a backfill …

HOOKIPA Announces Issuance of US and European Patents

HOOKIPA Announces Issuance of US and European Patents Content Import Mon, 08/03/2020 - 07:00 HOOKIPA Announces Issuance of US and European Patents August 3, 2020 at 7:00 AM EDT This release is a backfill from a News Wire Investors …
Show more

Hookipa Pharma Frequently Asked Questions

  • When was Hookipa Pharma founded?

    Hookipa Pharma was founded in 2011.

  • How many employees does Hookipa Pharma have?

    Hookipa Pharma has 60 employees.

  • What is Hookipa Pharma revenue?

    Latest Hookipa Pharma annual revenue is $11.9 m.

  • What is Hookipa Pharma revenue per employee?

    Latest Hookipa Pharma revenue per employee is $199 k.

  • Who are Hookipa Pharma competitors?

    Competitors of Hookipa Pharma include ExeVir Bio, Psicologia Viva and Brightline.

  • Where is Hookipa Pharma headquarters?

    Hookipa Pharma headquarters is located at Helmut-Qualtinger-Gasse 2, Wien.

  • Where are Hookipa Pharma offices?

    Hookipa Pharma has offices in Wien and New York.

  • How many offices does Hookipa Pharma have?

    Hookipa Pharma has 2 offices.